FA
SRNE

Fortis Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Fortis Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,581
Closed -$95K – 342
2018
Q3 		$95K Buy
+21,581
New +$95K 0.05% 160